FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046245870> ?p ?o ?g. }

• W2046245870 endingPage "131" @default.
• W2046245870 startingPage "121" @default.
• W2046245870 abstract "Widely used chemotherapeutic breast cancer drugs such as Tamoxifen citrate (TC), Capecitabine (CP) and Epirubicin (EP) are known to cause various cardiovascular side-effects among long term cancer survivors. Vascular modulation warrants nitric oxide (NO) signal transduction, which targets the vascular endothelium. We hypothesize that TC, CP and EP interference with the nitric oxide downstream signaling specifically, could lead to cardiovascular dysfunctions. The results demonstrate that while all three drugs attenuate NO and cyclic guanosine mono-phosphate (cGMP) production in endothelial cells, they caused elevated levels of NO in the plasma and RBC. However, PBMC and platelets did not show any significant changes under treatment. This implies that the drug effects are specific to the endothelium. Altered eNOS and phosphorylated eNOS (Ser-1177) localization patterns in endothelial cells were observed following drug treatments. Similarly, the expression of phosphorylated eNOS (Ser-1177) protein was decreased under the treatment of drugs. Altered actin polymerization was also observed following drug treatment, while addition of SpNO and 8Br-cGMP reversed this effect. Incubation with the drugs decreased endothelial cell migration whereas addition of YC-1, SC and 8Br-cGMP recovered the effect. Additionally molecular docking studies showed that all three drugs exhibited a strong binding affinity with the catalytic domain of human sGC. In conclusion, results indicate that TC, CP and EP cause endothelial dysfunctions via the NO–sGC–cGMP pathway and these effects could be recovered using pharmaceutical agonists of NO signaling pathway. Further, the study proposes a combination therapy of chemotherapeutic drugs and cGMP analogs, which would confer protection against chemotherapy mediated vascular dysfunctions in cancer patients." @default.
• W2046245870 created "2016-06-24" @default.
• W2046245870 creator A5005176596 @default.
• W2046245870 creator A5013077100 @default.
• W2046245870 creator A5038753752 @default.
• W2046245870 creator A5042067410 @default.
• W2046245870 creator A5050658753 @default.
• W2046245870 creator A5057490217 @default.
• W2046245870 creator A5074956754 @default.
• W2046245870 creator A5090274656 @default.
• W2046245870 date "2013-06-01" @default.
• W2046245870 modified "2023-09-24" @default.
• W2046245870 title "Breast cancer drugs dampen vascular functions by interfering with nitric oxide signaling in endothelium" @default.
• W2046245870 cites W1781455635 @default.
• W2046245870 cites W1966467785 @default.
• W2046245870 cites W1973415616 @default.
• W2046245870 cites W1982615613 @default.
• W2046245870 cites W1987013989 @default.
• W2046245870 cites W1995206479 @default.
• W2046245870 cites W1999087883 @default.
• W2046245870 cites W1999325366 @default.
• W2046245870 cites W2000738117 @default.
• W2046245870 cites W2000861757 @default.
• W2046245870 cites W2005007438 @default.
• W2046245870 cites W2009523688 @default.
• W2046245870 cites W2010332625 @default.
• W2046245870 cites W2012817678 @default.
• W2046245870 cites W2023122135 @default.
• W2046245870 cites W2029587579 @default.
• W2046245870 cites W2030984782 @default.
• W2046245870 cites W2031467354 @default.
• W2046245870 cites W2039446847 @default.
• W2046245870 cites W2053920394 @default.
• W2046245870 cites W2054915645 @default.
• W2046245870 cites W2055394671 @default.
• W2046245870 cites W2056918035 @default.
• W2046245870 cites W2057472285 @default.
• W2046245870 cites W2064554520 @default.
• W2046245870 cites W2064951152 @default.
• W2046245870 cites W2065334138 @default.
• W2046245870 cites W2075805622 @default.
• W2046245870 cites W2076569308 @default.
• W2046245870 cites W2077939517 @default.
• W2046245870 cites W2085825922 @default.
• W2046245870 cites W2090890592 @default.
• W2046245870 cites W2095495393 @default.
• W2046245870 cites W2099772783 @default.
• W2046245870 cites W2100837269 @default.
• W2046245870 cites W2119279409 @default.
• W2046245870 cites W2141647078 @default.
• W2046245870 cites W2144198949 @default.
• W2046245870 cites W2153338989 @default.
• W2046245870 cites W2158186070 @default.
• W2046245870 cites W2158855816 @default.
• W2046245870 cites W2159970886 @default.
• W2046245870 cites W2169024535 @default.
• W2046245870 cites W34964156 @default.
• W2046245870 cites W4230252742 @default.
• W2046245870 doi "https://doi.org/10.1016/j.taap.2013.03.011" @default.
• W2046245870 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23531514" @default.
• W2046245870 hasPublicationYear "2013" @default.
• W2046245870 type Work @default.
• W2046245870 sameAs 2046245870 @default.
• W2046245870 citedByCount "27" @default.
• W2046245870 countsByYear W20462458702014 @default.
• W2046245870 countsByYear W20462458702015 @default.
• W2046245870 countsByYear W20462458702016 @default.
• W2046245870 countsByYear W20462458702017 @default.
• W2046245870 countsByYear W20462458702018 @default.
• W2046245870 countsByYear W20462458702019 @default.
• W2046245870 countsByYear W20462458702020 @default.
• W2046245870 countsByYear W20462458702021 @default.
• W2046245870 countsByYear W20462458702022 @default.
• W2046245870 countsByYear W20462458702023 @default.
• W2046245870 crossrefType "journal-article" @default.
• W2046245870 hasAuthorship W2046245870A5005176596 @default.
• W2046245870 hasAuthorship W2046245870A5013077100 @default.
• W2046245870 hasAuthorship W2046245870A5038753752 @default.
• W2046245870 hasAuthorship W2046245870A5042067410 @default.
• W2046245870 hasAuthorship W2046245870A5050658753 @default.
• W2046245870 hasAuthorship W2046245870A5057490217 @default.
• W2046245870 hasAuthorship W2046245870A5074956754 @default.
• W2046245870 hasAuthorship W2046245870A5090274656 @default.
• W2046245870 hasConcept C11960822 @default.
• W2046245870 hasConcept C126322002 @default.
• W2046245870 hasConcept C185592680 @default.
• W2046245870 hasConcept C2776992346 @default.
• W2046245870 hasConcept C2777622882 @default.
• W2046245870 hasConcept C2778326061 @default.
• W2046245870 hasConcept C2780994212 @default.
• W2046245870 hasConcept C502942594 @default.
• W2046245870 hasConcept C519581460 @default.
• W2046245870 hasConcept C55493867 @default.
• W2046245870 hasConcept C62478195 @default.
• W2046245870 hasConcept C71924100 @default.
• W2046245870 hasConcept C98274493 @default.
• W2046245870 hasConceptScore W2046245870C11960822 @default.
• W2046245870 hasConceptScore W2046245870C126322002 @default.

• next